Exane Derivatives’s Southern Company SO Stock Holding History
Bought
Maintained
Sold
Other funds holding SO
Exane Derivatives's SO Position: Q2 2022 in Review
Exane Derivatives reduced its Southern Company (SO) stake by 100% in Q2 2022, selling an estimated $788K and leaving 17 shares worth $1.21K. The position accounts for ﹤0.01% of the portfolio, ranked #488.
Exane Derivatives first reported a position in SO in Q3 2016 and has held it in 21 quarters since. The position peaked at $5.94M in Q2 2018. 1,680 funds tracked by Wall St. Rank hold SO as of Q2 2022.
- Exane Derivatives held 17 shares of Southern Company worth $1.21K as of Q2 2022.
- Exane Derivatives sold 10,727 Southern Company shares in Q2 2022, an estimated $788K.
- Southern Company made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #488 holding.
- Exane Derivatives first reported a position in Southern Company in Q3 2016 and has held it in 21 quarters since.
- Exane Derivatives's Southern Company position peaked at $5.94M in Q2 2018.
- 1,680 funds tracked by Wall St. Rank held Southern Company as of Q2 2022.
Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.